News
Genedrive PLC - Publication of Genedrive Performance Data in Gut
Studies in UK, France and South Africa showed > 98% sensitivity and 100% specificity across all major HCV genotypes. genedrive plc, the near patient molecular diagnostics company, today announces the publication of analytical performance and field evaluation studies of its Genedrive ® HCV ID Kit in Europe and Africa in the prestigious BMJ Gut, a leading...
Studies in UK, France and South Africa showed > 98% sensitivity and 100% specificity across all major HCV genotypes. genedrive plc, the near patient molecular diagnostics company, today announces the publication of analytical performance and field evaluation studies of its Genedrive ® HCV ID Kit in Europe and Africa in the prestigious BMJ Gut, a leading...